Urgent.News

What's breaking now, across hundreds of outlets.

Finance & Markets

Goldman Sachs’ economic outlook for 2027

Goldman Sachs’ economic outlook for 2027

Goldman Sachs' latest economic outlook for 2027 anticipates a global real gross domestic product (GDP) growth of 2.8%, slightly higher than their previous estimate of 2.7% for 2026. However, Goldman cautions that risks are present on the downside side. The brokerage attributes this projected growth to lower energy prices and continued investment in artificial intelligence, which is offset by tighter financial conditions and more balanced fiscal policies.

Looking ahead, Goldman Sachs predicts a deceleration in inflation throughout 2027, as the effects of U.S. tariffs, energy, and AI-related pressures diminish. Consequently, the firm anticipates only minor, stepwise monetary policy tightening in major economies early in the year, followed by gradual normalization cuts later. This assessment is based on observations from Goldman analysts, including Andrea Ferrario, who noted that markets have already adjusted their expectations for growth downward across different regions over recent months.

Despite some strength in valuation re-set of risky assets, the Risk Appetite Indicator remains close to zero, suggesting a lowered benchmark for risky assets to generate positive returns if growth remains robust next year.

In terms of monetary policy, Goldman maintains a more accommodative stance than market pricing for next year, particularly regarding the European Central Bank and the Federal Reserve. For the Federal Reserve, Goldman projects 25 basis point interest rate hikes in December and March 2027, followed by gradual reductions starting in November. The CME FedWatch tool indicates traders are pricing in a 25 basis point rate hike in December and January 2027, after which the key policy rate is expected to remain unchanged.

Goldman identifies three primary risks to their baseline view of steady growth in 2027. First, higher energy prices could arise from renewed tensions in Iran. Second, fiscal risks might lead to increases in long-term yields. Lastly, disappointments in artificial intelligence capital expenditure growth may also pose challenges to their positive outlook.

Rewritten by urgent.news; may contain errors — check the original.

Source: investing.com

Read the original at investing.com →

Report a problem with this story

More in Finance & Markets

Marzetti: 3 Key Takeaways for Long-Term Investors

Chick-fil-A's permanent spicy sauce extends a 43-year partnership, potentially giving Marzetti a foodservice anchor that retail volatility cannot easily shake.

  • Marzetti's net sales declined 2.4% to $481.5 million in Q1 2027 due to lower organic volume.
  • Bachan's Japanese barbecue sauce brand drove 2% retail segment growth, with sales up 10.7%.
  • Marzetti expanded partnerships with Chick-fil-A and negotiated price increases to protect margins.

Where Will USA Rare Earth Stock Be in 5 Years? This Mine Holds the Keys.

USA Rare Earth is building out its mine-to-magnet supply chain, and the Round Top mine in Texas will be an important part of its growth.

  • USA Rare Earth aims to reduce U.S. reliance on Chinese rare-earth supply.
  • $1.6 billion government funding supports USAR's rare-earth mining and processing.
  • Round Top mine in Texas crucial for USAR's long-term success and production by 2030.

Alamar Biosciences: 3 Key Takeaways for Long-Term Investors

Clinical diagnostics is the next test: the ARGO HT/DX instrument heads to FDA review by late 2027, a step beyond academic research.

  • Alamar Biosciences raises 2026 revenue guidance to $121-$123 million
  • NULISA platform profiles 80,000 samples for U.K. Biobank Vanguard study
  • ARGO HT/DX clinical instrument to receive FDA marketing authorization by late 2027

More from Sunday 22 November →